(0.30%) 5 477.00 points
(0.17%) 39 186 points
(0.82%) 17 879 points
(2.32%) $83.43
(-4.23%) $2.49
(-0.06%) $2 338.30
(0.05%) $29.58
(-1.24%) $989.50
(-0.11%) $0.932
(-0.07%) $10.67
(0.09%) $0.791
(1.05%) $86.62
Live Chart Being Loaded With Signals
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland...
Stats | |
---|---|
Dagens volum | 330 887 |
Gjennomsnittsvolum | 336 670 |
Markedsverdi | 1.31B |
EPS | $-0.940 ( Q1 | 2023-05-05 ) |
Last Dividend | $0.100 ( 2012-09-26 ) |
Next Dividend | $0 ( N/A ) |
P/E |
-62.49 (Sector) 42.63 (Industry) 0 |
ATR14 | $0.901 (0.75%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-13 | Davis Stephen L | Sell | 500 | Common Stock |
2023-06-13 | Hasenmaier Joachim A. | Sell | 2 004 | Common Stock |
2023-06-13 | Eyl Steven M. | Buy | 4 056 | Common Stock |
2023-06-13 | Eyl Steven M. | Buy | 33 111 | Common Stock |
2022-02-28 | Eyl Steven M. | Buy | 20 000 | Non-Qualified Stock Option (right to buy) |
INSIDER POWER |
---|
-9.30 |
Last 100 transactions |
Buy: 575 941 | Sell: 596 011 |
Volum Korrelasjon
Heska Corp Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Heska Corp Korrelasjon - Valuta/Råvare
Heska Corp Økonomi
Annual | 2022 |
Omsetning: | $257.31M |
Bruttogevinst: | $111.17M (43.20 %) |
EPS: | $-1.780 |
FY | 2022 |
Omsetning: | $257.31M |
Bruttogevinst: | $111.17M (43.20 %) |
EPS: | $-1.780 |
FY | 2021 |
Omsetning: | $253.74M |
Bruttogevinst: | $105.79M (41.69 %) |
EPS: | $-0.110 |
FY | 2020 |
Omsetning: | $197.32M |
Bruttogevinst: | $81.29M (41.20 %) |
EPS: | $-1.660 |
Financial Reports:
No articles found.
Heska Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.100 | 2012-03-28 |
Last Dividend | $0.100 | 2012-09-26 |
Next Dividend | $0 | N/A |
Payout Date | 2012-10-10 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $0.300 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.59 | -- |
Div. Sustainability Score | 3.02 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.192 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0.300 | 4.08% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
26 Sep 2012 | $0.100 | 12 Sep 2012 | 28 Sep 2012 | 10 Oct 2012 |
27 Jun 2012 | $0.100 | 08 May 2012 | 29 Jun 2012 | 10 Jul 2012 |
28 Mar 2012 | $0.100 | 24 Feb 2012 | 30 Mar 2012 | 10 Apr 2012 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Diamond | 2024-09-16 | Monthly | 14 | 15.03% | 9.60 |
DMLP | Dividend Diamond | 2024-04-26 | Quarterly | 22 | 10.71% | 9.35 |
OXSQ | Dividend Diamond | 2024-09-16 | Monthly | 21 | 12.73% | 9.02 |
ARLP | Dividend Royal | 2024-05-07 | Quarterly | 26 | 9.67% | 8.87 |
PNNT | Dividend Royal | 2024-06-14 | Monthly | 18 | 9.49% | 8.82 |
MFIC | Dividend Royal | 2024-06-11 | Quarterly | 21 | 10.89% | 8.79 |
SPOK | Dividend Royal | 2024-05-23 | Quarterly | 20 | 8.73% | 8.72 |
PSEC | Dividend Royal | 2024-06-25 | Monthly | 21 | 9.03% | 8.65 |
SBLK | Dividend Royal | 2024-06-06 | Quarterly | 17 | 13.10% | 8.63 |
GBDC | Dividend Royal | 2024-11-29 | Bi-Monthly | 15 | 8.53% | 8.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.106 | 1.500 | -2.12 | -3.18 | [0 - 0.5] |
returnOnAssetsTTM | -0.0230 | 1.200 | -0.766 | -0.920 | [0 - 0.3] |
returnOnEquityTTM | -0.0324 | 1.500 | -1.472 | -2.21 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 5.64 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.82 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.96 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.185 | -1.500 | 6.92 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -8.49 | 1.000 | -4.25 | -4.25 | [3 - 30] |
operatingCashFlowPerShareTTM | -1.186 | 2.00 | -0.395 | -0.791 | [0 - 30] |
freeCashFlowPerShareTTM | -1.417 | 2.00 | -0.708 | -1.417 | [0 - 20] |
debtEquityRatioTTM | 0.262 | -1.500 | 8.95 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.429 | 1.000 | 6.18 | 6.18 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0920 | 1.000 | -3.84 | -3.84 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.113 | 1.000 | -1.737 | -1.737 | [0.2 - 2] |
assetTurnoverTTM | 0.217 | 0.800 | -1.886 | -1.508 | [0.5 - 2] |
Total Score | 3.02 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -91.49 | 1.000 | -9.34 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0324 | 2.50 | -0.946 | -2.21 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.417 | 2.00 | -0.472 | -1.417 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -1.186 | 2.00 | -0.395 | -0.791 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.305 | 1.500 | -5.37 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0957 | 1.000 | -4.89 | 0 | [0.1 - 0.5] |
Total Score | -2.64 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Heska Corp
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.